FDA Clears Olastrocel Trial Expansion - Quiz - MDSpire

FDA Clears Olastrocel Trial Expansion

Additional patients with ongoing opioid use are being enrolled as Creative Medical prepares for potential Phase 3 discussions with the FDA.

  • By

  • Kathryn Wighton

  • June 22, 2026

  • 3 min

Share

Original Source(s)

FDA Clears Olastrocel Trial Expansion

  • by Kathryn Wighton

  • June 22, 2026

Related Content

Surgery May Improve Outcomes in Arm Fractures

Swedish registry analysis linked surgical treatment with better patient-reported function in comminuted intra-articular distal radius fractures, while other fracture patterns showed limited benefit.

Comparative analysis of unilateral biportal endoscopy and minimally invasive transforaminal lumbar interbody fusion in treating lumbar spinal brucellosis

RA Prescribing Patterns Shift Over 15 Years

An aging Japanese cohort with rheumatoid arthritis saw increasing use of targeted synthetic therapies as glucocorticoid use declined.